Answers are grounded in this paper and cite their sources.
The RENASICA II registry highlights significant gaps in STEMI care in Mexico, with low rates of primary PCI (15%) and high 30-day mortality (10%), emphasizing the need for regional quality improvement initiatives.
Cardiovascular diseases are the leading cause of death, worldwide, with disproportionate representation in low- and middle-income countries (LMICs). The Registro Nacional de los Síndromes Coronarios Agudos II (RENASICA II) investigators reported smoking, hypertension and diabetes were the main risk factors among Mexican patients presenting with ST-elevation myocardial infarction (STEMI). Fibrinolytic therapy was administered to 37%. Primary percutaneous coronary intervention (PPCI) was performed in only 15% of patients. 30-day mortality was 10%. This study highlights the importance of conducting regional registries for quality improvement.
No takes yet. Share an insight, caveat, or question.
Jassim Al Suwaidi (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: